Advantages and disadvantages of current prophylactic vaccines against HPV. [electronic resource]
Producer: 20100416Description: 471-7 p. digitalISSN:- 1873-5487
- Drug Approval
- Female
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
- Humans
- Incidence
- Papillomaviridae -- immunology
- Papillomavirus Infections -- complications
- Papillomavirus Vaccines -- economics
- Randomized Controlled Trials as Topic
- Risk Factors
- Treatment Outcome
- Uterine Cervical Neoplasms -- prevention & control
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.